|
1
|
Andrade AF, Borges KS, Castro-Gamero AM,
Silveira VS, Suazo VK, Oliveira JC, Moreno DA, de Paula Queiroz RG,
Scrideli CA and Tone LG: Zebularine induces chemosensitization to
methotrexate and efficiently decreases AhR gene methylation in
childhood acute lymphoblastic leukemia cells. Anticancer Drugs.
25:72–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stiff PJ, Unger JM, Cook JR, Constine LS,
Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS, et al:
Autologous transplantation as consolidation for aggressive
non-Hodgkin's lymphoma. N Engl J Med. 369:1681–1690. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Plosker GL and Figgitt DP: A review of its
use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Drugs. 63:803–843. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Till KJ, Coupland SE and Pettitt AR:
Motility and trafficking in B-cell non-Hodgkin's lymphoma (Review).
Int J Oncol. 45:5–12. 2014.PubMed/NCBI
|
|
5
|
Moreno-Martínez D, Nomdedeu M,
Lara-Castillo MC, Etxabe A, Pratcorona M, Tesi N, Díaz-Beyá M,
Rozman M, Montserrat E, Urbano-Ispizua A, et al: XIAP inhibitors
induce differentiation and impair clonogenic capacity of acute
myeloid leukemia stem cells. Oncotarget. 12:4337–4346. 2014.
|
|
6
|
Wang A, Zhang B, Zhang J and Wu W and Wu
W: Embelin-induced brain glioma cell apoptosis and cell cycle
arrest via the mitochondrial pathway. Oncol Rep. 29:2473–2478.
2013.PubMed/NCBI
|
|
7
|
Dai Y, Jiao H, Teng G, Wang W, Zhang R,
Wang Y, Hebbard L, George J and Qiao L: Embelin reduces
colitis-associated tumorigenesis through limiting IL-6/STAT3
signaling. Mol Cancer Ther. 13:1206–1216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yao GH, Luan JF, Ye D, Yan JM, Lei QH, Zhu
PY and Jin J: Effects of triptolide on proliferation and apoptosis
of Jurkat cell line in acute T lymphocytic leukemia. Zhongguo Shi
Yan Xue Ye Xue Za Zhi. 16:506–509. 2008.(In Chinese). PubMed/NCBI
|
|
9
|
Hu R, Wu B, Zhang GJ, Wang HT, Zhu K, Yang
W and Liu ZG: Effect of Embelin on proliferation, differentiation
and apoptosis of HL-60 cells. Zhonghua Xue Ye Xue Za Zhi.
31:442–445. 2010.(In Chinese). PubMed/NCBI
|
|
10
|
Marsh JL, Jackman CP, Tang SN, Shankar S
and Srivastava RK: Embelin suppresses pancreatic cancer growth by
modulating tumor immune microenvironment. Front Biosci (Landmark
Ed). 19:113–125. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng YJ1, Jiang HS, Hsu SL, Lin LC, Wu
CL, Ghanta VK and Hsueh CM: XIAP-mediated protection of H460 lung
cancer cells against cisplatin. Eur J Pharmacol. 627:75–84. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deveraux QL, Takahashi R, Salvesen GS and
Reed JC: X-linked IAP is a direct inhibitor of cell-death
proteases. Nature. 388:300–304. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao L, Shan B, Du Y, Wang M, Liu L and
Ren FZ: Periplocin from Cortex periplocae inhibits cell growth and
down-regulates survivin and c-myc expression in colon cancer in
vitro and in vivo via beta-catenin/TCF signaling. Oncol Rep.
24:375–383. 2010.PubMed/NCBI
|
|
14
|
Danial NN: Bcl-2 family proteins: Critical
checkpoints of apoptotic cell death. Clin Cancer Res. 13:7254–7263.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Silke J and Vucic D: IAP family of cell
death and signaling regulators. Methods Enzymol. 545:35–65. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuwana T and Newmeyer DD: Bcl-2-family
proteins and the role of mitochondria in apoptosis. Curr Opin Cell
Biol. 15:691–699. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bao W, Zhu F, Duan Y, Yang Y and Cai H:
HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma
cells by targeting XIAP. Biomed Pharmacother. 70:97–102. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen FH, Qu HY and Sui GJ: Effects of
apoptosis protein XIAP inhibito on the apoptosis and sensitivity of
chemotherapy in A549 cell. Chin J Lung Cancer. 11:368–372. 2008.(In
Chinese).
|
|
19
|
Nikolovska-Coleska Z, Xu L, Hu Z, et al:
Discovery of embelin as a cell-permeable, small-molecular weight
inhibitor of XIAP through structure-based computational screening
of a traditional herbal medicine three-dimensional structure
database. J Med Chem. 47:2430–2440. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Irshad S, Ashworth A and Tutt A:
Therapeutic potential of PARP inhibitors for metastatic breast
cancer. Expert Rev Anticancer Ther. 11:1243–1251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nikrad M, Johnson T, Puthalalath H,
Coultas L, Adams J and Kraft AS: The proteasome inhibitor
bortezomib sensitizes cells to killing by death receptor ligand
TRAIL via BH3-only proteins Bik and Bim. Mol Cancer Ther.
4:443–449. 2005.PubMed/NCBI
|
|
22
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ulukaya E, Acilan C and Yilmaz Y:
Apoptosis: Why and how does it occur in biology. Cell Biochem
Funct. 29:468–480. 2011. View
Article : Google Scholar : PubMed/NCBI
|
